JB Consulting MDP Limited is a specialist advisory firm operating at the intersection of science, strategy, and innovation within the life sciences sector. With a core focus on pharmaceutical and diagnostic industries, the company provides expert guidance in product (pharmaceuticals, diagnostics and devices) development, regulatory strategy, and commercialisation pathways and promotional and advisory signatory. JB Consulting partners with global biotech and medtech clients to accelerate innovation from bench to bedside. The firm’s services span early-stage asset evaluation, clinical development planning, market access strategy, and portfolio optimisation. Leveraging deep domain expertise, JB Consulting helps clients navigate complex regulatory environments and align scientific potential with commercial viability. In recent years, JB Consulting has become a thought leader in precision medicine, particularly in the dynamic interplay between therapeutics and biomarkers. The firm supports clients in integrating diagnostic insights into therapeutic development, enabling more targeted, effective, and personalised treatment approaches. With a reputation for scientific rigour, strategic clarity, and collaborative engagement, JB Consulting MDP Limited is committed to advancing healthcare innovation. Its mission is to empower life science companies to deliver transformative solutions that improve patient outcomes and redefine standards of care.